4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Fortrea Holdings Inc. (FTRE) operates in the Biotechnology industry and is headquartered in Durham, United States with about 14,000 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, FTRE reported $2.7B in revenue and ($986M) in net income.
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide.
Interactive charts & full statements → Open the FTRE valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $2.7B | $2.7B | $2.8B | $2.8B |
| Gross Profit | $504M | $534M | $591M | $724M |
| Operating Income (EBIT) | ($31M) | ($112M) | $53M | $223M |
| Net Income | ($986M) | ($328M) | ($25M) | $186M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $636M | $660M | $701M | $710M | $651M | — |
| Gross Profit | $124M | $131M | $123M | $134M | $116M | — |
| Operating Income (EBIT) | $3M | $9M | ($4M) | ($11M) | ($25M) | — |
| Net Income | ($24M) | ($32M) | ($16M) | ($375M) | ($563M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $2.7B | $3.6B | $4.3B | $4.3B | — |
| Total Liabilities | $2.2B | $2.2B | $2.6B | $945M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive FTRE viewer.
About TickerBase · Data methodology & sources